教授综述
Professor Walter Van Dyck is Associate Professor of Technology and Innovation Management at Vlerick Business School. He is Partner and member of the Executive Committee as Director Open Programmes of the School’s Executive Education Department. He obtained a Doctorate of Business Administration with the highest honours from Cranfield University, School of Management (UK), a BA and MA from the Royal Military Academy Brussels, specialising in electronics and telecom, and an MBA from Vlerick. Prior to joining academia, he was Senior Strategy Consultant with PricewaterhouseCoopers and IBM in the fields of R&D and innovation management, predominantly active in global pharmaceutical and biotech companies. He is also Research Fellow in the Faculty of Business and Economics at KU Leuven (KUL). His research and teaching focus on strategic innovation management in global and multinational companies, corporate venturing and business modelling in emerging technology fields.
现任
Associate Professor of Technology and Innovation Management at Vlerick Business School
教授的课程
Innovation Management
研究领域
Strategic innovation management in global and multinational companies, corporate venturing and business modelling in emerging technology fields
教育背景
PhD of Business Administration, Cranfield University, School of Management (UK)
BA and MA ofelectronics and telecom, the Royal Military Academy Brussels,
MBA, Vlerick Business School
工作经历
Prior to joining academia, he was Senior Strategy Consultant with PricewaterhouseCoopers and IBM in the fields of R&D and innovation management, predominantly active in global pharmaceutical and biotech companies.
学术论文
Articles in other (un)refereed journals
Van Dyck W.2012. Building and leveraging your ecosystem to spark innovation-based growth. Ivey Business Journal, 76(2): 7-9.
Van Dyck W. Gassull D. Vértes G. Prateek J. Palaniappan M. Schulthess D. Tambuyzer E. Hudson R. Moran N.2012. Unlocking the value of personalised healthcare in Europe—breast cancer stratification. Health Policy and Technology, 1(2): 63-68.
Van Dyck W. Gassull D. Prateek J. Palaniappan M. Schulthess D. Tambuyzer E. Hudson R. Moran N.2012. Acute coronary syndrome: what is the cost-effectiveness of prevention, point-of-care technology and telemonitoring?. Health Policy and Technology, 1(3): 173-177.
Leten B. Van Dyck W.2012. Corporate venturing: Strategies and success factors. Review of Business and Economic Literature, 57(4): 242-243.
Stremersch S. Van Dyck W.2009. Marketing of the life sciences: a new framework and research agenda for a nascent field. Journal of Marketing, 73(July): 4-30.
Van Dyck W. Allen P.2006. Pharmaceutical Discovery as a Complex system of decisions: the case of front-loaded experimentation. Emergence: Complexity & Organization, 8(3): 40-56.
Book Chapters
Van Dyck W. Aelbrecht T.2010. Going beyond the pill: business transformation through corporate venturing at Janssen Pharmaceutica. In: Silberzahn P. Van Dyck W. The balancing act of innovation (pp. 233-249).
Van Dyck W.2004. Introducing advanced technology in pharmaceutical R&D: The need for a new paradigm?. Festel Capital.
Van Dyck W.1997. CIM invoeren in de praktijk: een kwestie van strategie. In: Ed. CIM Praktijkboek: Computer Integrated Manufacturing in België, een praktische handleiding gebaseerd op reële gevalstudies (pp. 21-44). Academia Press.
Van Dyck W.1997. DAIKIN Europe: CIM ter ondersteuning van een JIT concept. In: Ed. CIM Praktijkboek: Computer Integrated Manufacturing in België, een praktische handleiding gebaseerd op reële gevalstudies Academia Press.
著作
Silberzahn P. Van Dyck W.2010. The balancing act of innovation. LannooCampus.
